Clinical trial · Observational
Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older
NCT04526314CI-TRIAL-00046794completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study was to assess survival trends in elderly patients with stage III colon cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Adenocarcinoma | Colon Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| observational | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Stage 3 with adjuvant chemotherapy
- interventionNames
- Other: observational
- label
- Stage 3 without adjuvant chemotherapy
- interventionNames
- Other: observational
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 2007-2014
- description
- months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: • Stage 3 colon adenocarcinoma Exclusion Criteria: * Rectal tumors * Patients receiving neo-adjuvant chemotherapy or radiotherapy * Tumours of the appendix * Tumours with histology other than adenocarcinoma
References
Publications (1)
- DERIVEDBadic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Queneherve L. Prognostic factors for stage III colon cancer in patients 80 years of age and older. Int J Colorectal Dis. 2021 Apr;36(4):811-819. doi: 10.1007/s00384-021-03861-6. Epub 2021 Feb 2. PMID 33528749